Kate Rochlin
Chief Operating Officer IN8Bio
Seminars
Thursday 11th December 2025
Activating the Potential of Gamma Delta T-Cells: A Next-Generation Approach to Minimize CRS & Rethink TCE Safety in Autoimmunity & Oncology
2:30 pm
- How to selectively target powerful but rare cell-types such as gamma-delta T cells to drive target cell elimination.
- Solving the scarcity issue: How to unlock the power of gamma delta TCEs through novel design or mechanism to expand and activate gamma-delta T cells in vivo.
- Discussion of the shifting paradigm and risk tolerance from Oncology to Autoimmune indications in TCEs, how to drive safer target elimination & immune reset
